Erratum to “Hydroxychloroquine Effects on TLR Signalling: Underexposed but Unneglectable in COVID-19”

Erratum to “Hydroxychloroquine Effects on TLR Signalling: Underexposed but Unneglectable in COVID-19”

Bibliographic Details
Main Authors:	Aliede E. in ‘t Veld, Manon A. A. Jansen, Luuk C. A. Ciere, Matthijs Moerland
Format:	Article
Language:	English
Published:	Hindawi Limited 2021-01-01
Series:	Journal of Immunology Research
Online Access:	http://dx.doi.org/10.1155/2021/9789246

Similar Items

Hydroxychloroquine Effects on TLR Signalling: Underexposed but Unneglectable in COVID-19
by: Aliede E. in ‘t Veld, et al.
Published: (2021-01-01)

Overdressed and Underexposed or Underdressed and Overexposed?
by: Lori G. Beaman
Published: (2013-12-01)

Hydroxychloroquine, COVID-19, and prophylaxis
by: Viroj Wiwanitkit
Published: (2020-01-01)

Chloroquine, hydroxychloroquine and COVID-19
by: Erickson, T. B., et al.
Published: (2020)

Revisit Retinex Theory: Towards a Lightness-Aware Restorer for Underexposed Images
by: Lin Zhang, et al.
Published: (2020-01-01)

Role of hydroxychloroquine in multidrug treatment of COVID-19
by: Peter A. McCullough, et al.
Published: (2021-09-01)

The use of Hydroxychloroquine in the Treatment of COVID-19
by: Kamer TECEN-YÜCEL, et al.
Published: (2020-09-01)

Chloroquine and hydroxychloroquine for COVID-19 treatment
by: Dwi Aris Agung Nugrahaningsih, et al.
Published: (2020-05-01)

Chloroquine and hydroxychloroquine in the context of COVID-19
by: Ashutosh M Shukla, et al.
Published: (2020-04-01)

Hydroxychloroquine and QTc: beyond COVID-19
by: Alberto Castagna, et al.
Published: (2020-10-01)

Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients
by: Javad Mahmoudi, et al.
Published: (2021-01-01)

Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
by: Tzu-Chuan Ho, et al.
Published: (2021-02-01)

Hydroxychloroquine as Prophylaxis for COVID-19: A Review
by: Manuela Monti, et al.
Published: (2020-12-01)

Hydroxychloroquine in COVID-19 Patients: Pros and Cons
by: Nour K. Younis, et al.
Published: (2020-11-01)

Chloroquine, hydroxychloroquine, and COVID-19, the Libyan prospective
by: Abdalla Salem Elhwuegi
Published: (2020-01-01)

Updates on Hydroxychloroquine in Prevention and Treatment of COVID-19
by: Alter, S., et al.
Published: (2022)

Hydroxychloroquine and dexamethasone in COVID-19: who won and who lost?
by: Claudio Ortolani, et al.
Published: (2020-09-01)

"Still Underexposed"? – Some Remarks On The Problematic Relationship Between Visual Communication, Political Science, and Civic Education
by: Benjamin Drechsel
Published: (2009-03-01)

Safety of hydroxychloroquine in healthcare workers for COVID-19 prophylaxis
by: Atiya R Faruqui, et al.
Published: (2021-01-01)

Rational use of chloroquine and hydroxychloroquine in times of COVID-19
by: Rosa Camila Lucchetta, et al.
Published: (2020-04-01)

Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19
by: Filippo Albani, et al.
Published: (2020-08-01)

Hydroxychloroquine-Associated Hypoglycemia in Hemodialysis Patients With COVID-19
by: Ahmet Burak Dirim, et al.
Published: (2020-10-01)

Therapeutic status of hydroxychloroquine in COVID-19: A review
by: Kirandeep Kaur, et al.
Published: (2020-01-01)

Proarrhythmic effects of chloroquine and hydroxychloroquine in the context of Covid-19
by: Carlos Enrique Salgado-Fuentes
Published: (2021-05-01)

Ethical Considerations of Hydroxychloroquine During the COVID-19 Pandemic
by: Amy Reese
Published: (2021-08-01)

Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-An observational study.
by: Andrew Ip, et al.
Published: (2020-01-01)

Risk versus Benefit of Using Hydroxychloroquine to Treat Patients with COVID-19
by: George G. Zhanel, et al.
Published: (2021-01-01)

Can hydroxychloroquine be protective against COVID-19-associated thrombotic events ?
by: Christian A. Devaux, et al.
Published: (2021-02-01)

The study of cardiotoxicity of hydroxychloroquine and azithromycine combination in hospitalized patients with COVID-19
by: Yu. N. Belenkov, et al.
Published: (2020-12-01)

Are promising mechanisms of hydroxychloroquine abolish COVID-19 activity? A review study
by: Yaareb J Mousa, et al.
Published: (2020-06-01)

Utility of hydroxychloroquine for COVID-19: Are we hoping against hope?
by: K C Manish, et al.
Published: (2021-01-01)

The Rise and Fall of Chloroquine/Hydroxychloroquine as Compassionate Therapy of COVID-19
by: Elangovan Manivannan, et al.
Published: (2021-05-01)

Hydroxychloroquine with azithromycin in patients hospitalized for mild and moderate COVID-19
by: Elisa Baranski Lamback, et al.
Published: (2021-03-01)

Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia
by: Nobuaki Mori, et al.
Published: (2021-02-01)

Involuntary Movements Following Administration of Hydroxychloroquine for COVID-19 Pneumonia
by: Emmaline Zantua Fernando, et al.
Published: (2021-01-01)

Hydroxychloroquine for chemoprophylaxis in COVID-19: A case of motivated perception?
by: B G Manjunath, et al.
Published: (2020-01-01)

The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19
by: Balakrishnan Sadasivam, et al.
Published: (2020-11-01)

Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine
by: Babayeva M, et al.
Published: (2020-10-01)

Hydroxychloroquine for prophylaxis and treatment of COVID-19 in health-care workers
by: I. Simova, et al.
Published: (2020-11-01)

Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
by: Samia Arshad, et al.
Published: (2020-08-01)